Test Your Knowledge on Nutritional Support Strategies in GLP-1 Drug Use

['Paul Basilio', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright'] Endocrinology Advisor 2025-07-11 14:01:52

Test Your Knowledge Question 1 Your patient with obesity is undergoing evaluation prior to initiation of GLP-1 therapy. The Advisory authors recommend screening and/or assessment for all of the following conditions relevant to GLP-1 use, EXCEPT which? The Advisory authors recommend screening and/or assessment for all of the following conditions relevant to GLP-1 use, EXCEPT which? In addition, patients should be evaluated for restrictive eating disorders, as these are general contraindications to GLP-1 therapy. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.